William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 659 shares at $43.02 ($28K) on 2025-09-11, disclosed to the SEC on 2025-09-12.
Seasonal sale ($28k) by Chief Financial Officer — this insider has traded AKRO in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |
| IRON | SELL | 2024-12-04 | $240K | — | Filing → |